ICU Medical, Inc.
ICUIHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframePart of the healthcare sector, ICU Medical, Inc. (ICUI) is listed under Medical Instruments & Supplies. With a market capitalization of $3.29B, it sits in mid-cap territory. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products.
Market Cap
$3.29B
Beta
0.74
P/E (TTM)
70.77
P/E (Fwd)
14.11
EPS (TTM)
$1.86
EPS (Fwd)
$9.33
ROE
2.3%
ROA
1.7%
Cash
$292.7M
Total Debt
$1.34B
Free CF
$387.1M
52W Change
0.8%
Annual Financials
Cash vs Debt
On the balance sheet, ICUI has $292.7M in cash with $1.34B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $387.1M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 2.3%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 1.7% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $2.28B (2022) to $2.23B (2025).
At over 50x earnings, ICUI carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. No single metric tells the full story. Reviewing ICUI's risk profile alongside its fundamentals and technical indicators provides a more complete picture.